Novartis to Acquire Synnovation Unit in Deal Worth Up to $3 Billion
WILMINGTON, DE — Novartis has agreed to acquire Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics, in a deal valued at up to $3 billion to expand its oncology pipeline, the …
Novartis to Acquire Synnovation Unit in Deal Worth Up to $3 Billion Read More